Furiex Pharmaceuticals, Inc. (NASDAQ:FURX) achieved its new 52 week high price of $19.54 where it was opened at $18.59 up 0.63 points or +3.40% by closing at $19.14. FURX transacted shares during the day were over 36,828 shares however it has an average volume of 99,729 shares.
FURX has a market capitalization $189.12 million and an enterprise value at $121.16 million. Trailing twelve months price to sales ratio of the stock was 20.90 while price to book ratio in most recent quarter was 1.80. In profitability ratios, operating profit margin in past twelve months appeared at -610.82%.
The company made a return on asset of -40.60% in past twelve months and return on equity of -74.72% for similar period. In the period of trailing 12 months it generated revenue amounted to $9.05 million gaining $0.92 revenue per share. Its year over year, quarterly growth of revenue was 23.20%.
According to preceding quarter balance sheet results, the company had $67.97 million cash in hand making cash per share at 6.88. The total debt was $0.00 billion. Moreover its current ratio according to same quarter results was 5.36 and book value per share was 10.61.
Looking at the trading information, the stock price history displayed that its S&P500 52 Week Change illustrated 16.72% where the stock price exhibited up beat from its 50 day moving average with $15.99 and remained above from its 200 Day Moving Average with $15.65.
FURX holds 9.88 million outstanding shares with 7.41 million floating shares where insider possessed 11.21% and institutions kept 73.10%.
No comments:
Post a Comment